Pacira Reports Phase 1 Trial Data Supporting Potential Of PCRX-201
15/5 14:30
(RTTNews) - Pacira BioSciences, Inc. (PCRX) reported new preliminary data which suggests that clinical immunogenicity does not reduce sustained improvements in knee pain, stiffness and function provided by its gene therapy candidate, PCRX-201, following local administration in pa...